2013•HeartRequires access

GW24-e0017 The clinical research of Bushen Huoxue therapy on depression of patients with parkinson’s disease

Bo Yeun Yang, Min Li, Yang Bo

Open publisher page 0 citations

Abstract

Objectives To study the effects of Bushenhuoxue Therapy on depression of patients with Parkinson’s disease. Methods Totally 96 patients were enrolled and randomised into two groups with 46 patients in the treatment group and 50 patients in the control group. Both groups were taking western medicine as basic treatment. The treatment group was treated with Bushen Huoxue Herbs additionally. The observation was carried out for 9 months. Using Encephalofluctuograph Technology (ET) and Hamilton Depression Scale (HAMD) to measure the changes of cerebral neurotransmitters and scale scores in both groups at baseline time, 3, 6 and 9 months later to evaluate the effects of Bushen Huoxue Herbs. Results In the treatment group, 5-hydroxytryptamine (5-HT), noradrenaline (NE)and Dopamine (DA)levels increased with statistical difference (P < 0.05), especially of 5-HT and DA levels (P < 0.01); compared to the control group, 5-HT and DA levels were increased significantly (P < 0.05). After treatment, the scores of the HAMD scale was significantly decreased (P < 0.05). No adverse effects were found in this trial. Conclusions Bushen Huoxue Therapy can improve depression of PD patients by increasing the levels of 5-HT, NE and DA in the brain and decreasing the scores of the HAMD scale with reliable effects.

About this research paper

What this paper is about

Objectives To study the effects of Bushenhuoxue Therapy on depression of patients with Parkinson’s disease. Methods Totally 96 patients were enrolled and randomised into two groups with 46 patients in the treatment group and 50 patients in the control group. Both groups were taking western medicine as basic treatment. The treatment group was treated with Bushen Huoxue Herbs additionally. The observation was carried out for 9 months. Using Encephalofluctuograph Technology (ET) and Hamilton Depression Scale (HAMD) to measure the changes of cerebral neurotransmitters and scale scores in both groups at baseline time, 3, 6 and 9 months later to evaluate the effects of Bushen Huoxue Herbs. Results In the treatment group, 5-hydroxytryptamine (5-HT), noradrenaline (NE)and Dopamine (DA)levels increased with statistical difference (P < 0.05), especially of 5-HT and DA levels (P < 0.01); compared to the control group, 5-HT and DA levels were increased significantly (P < 0.05). After treatment, the scores of the HAMD scale was significantly decreased (P < 0.05). No adverse effects were found in this trial. Conclusions Bushen Huoxue Therapy can improve depression of PD patients by increasing the levels of 5-HT, NE and DA in the brain and decreasing the scores of the HAMD scale with reliable effects.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objectives To study the effects of Bushenhuoxue Therapy on depression of patients with Parkinson’s disease. Methods Totally 96 patients were enrolled and randomised into two groups with 46 patients in the treatment group and 50 patients in the control group. Both groups were taking western medicine as basic treatment. The treatment group was treated with Bushen Huoxue Herbs additionally. The observation was carried out for 9 months. Using Encephalofluctuograph Technology (ET) and Hamilton Depression Scale (HAMD) to measure the changes of cerebral neurotransmitters and scale scores in both groups at baseline time, 3, 6 and 9 months later to evaluate the effects of Bushen Huoxue Herbs. Results In the treatment group, 5-hydroxytryptamine (5-HT), noradrenaline (NE)and Dopamine (DA)levels increased with statistical difference (P < 0.05), especially of 5-HT and DA levels (P < 0.01); compared to the control group, 5-HT and DA levels were increased significantly (P < 0.05). After treatment, the scores of the HAMD scale was significantly decreased (P < 0.05). No adverse effects were found in this trial. Conclusions Bushen Huoxue Therapy can improve depression of PD patients by increasing the levels of 5-HT, NE and DA in the brain and decreasing the scores of the HAMD scale with reliable effects.

Key concepts: Medicine, Hamd, Depression (economics), Internal medicine, Hamilton depression scale, Adverse effect, Dopamine, Quality of life (healthcare)

Related papers

Back to paper searchBrowse research topicsOriginal source
GW24-e0017 The clinical research of Bushen Huoxue therapy on depression of patients with parkinson’s disease — Research Paper | ScholarLens